SARAH GILL
- Type
- Non-physician practitioner · Physician Assistants & Advanced Practice Nursing Providers / Nurse Practitioner / Psychiatric/Mental Health
- Where
- SALEM, IN
- NPI
- 1447086707
- Received
- $1,003 in 54 records, 2024 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 39 | $699 |
| 2024 | General payment | 15 | $304 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $204 | 2024–2025 |
| ABBVIE INC. | 12 | $152 | 2025 |
| Vanda Pharmaceuticals Inc. | 4 | $147 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $100 | 2024–2025 |
| Lundbeck LLC | 6 | $100 | 2024–2025 |
| Alkermes, Inc. | 3 | $66 | 2024 |
| Neurocrine BioSciences, Inc. | 4 | $64 | 2024–2025 |
| Teva Pharmaceuticals USA, Inc. | 3 | $56 | 2024–2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $36 | 2024–2025 |
| Janssen Pharmaceuticals, Inc | 2 | $34 | 2024–2025 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 | 2025 |
| Noven Therapeutics, LLC | 1 | $18 | 2024 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Food and Beverage | 53 | $956 |
| Education | 1 | $46 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-10 | Otsuka America Pharmaceutical, Inc. | $16 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-11-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $20 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-18 | ABBVIE INC. | $3 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-11-12 | ABBVIE INC. | $10 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-11-04 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-10-29 | Janssen Pharmaceuticals, Inc | $21 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-10-22 | Vanda Pharmaceuticals Inc. | $33 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-10-15 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-10-01 | Otsuka America Pharmaceutical, Inc. | $10 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-09-17 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-09-03 | Lundbeck LLC | $16 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-08-28 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-08-20 | ABBVIE INC. | $15 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-08-13 | Teva Pharmaceuticals USA, Inc. | $20 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-08-06 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-07-30 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-07-23 | Vanda Pharmaceuticals Inc. | $36 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-07-22 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-07-09 | Lundbeck LLC | $14 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-02 | Vanda Pharmaceuticals Inc. | $36 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-06-25 | Teva Pharmaceuticals USA, Inc. | $21 | Food and Beverage | In-kind items and services | AUSTEDO XR Drug, Central Nervous System | 2025 | |
| 2025-06-18 | Vanda Pharmaceuticals Inc. | $41 | Food and Beverage | In-kind items and services | FANAPT Drug, SCHIZOPHRENIA | 2025 | |
| 2025-06-04 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-05-14 | Neurocrine BioSciences, Inc. | $15 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-30 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-04-23 | Otsuka America Pharmaceutical, Inc. | $21 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-16 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-16 | Lundbeck LLC | $17 | Food and Beverage | Cash or cash equivalent | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2025-04-02 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-03-26 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-03-06 | VERTEX PHARMACEUTICALS INCORPORATED | $20 | Food and Beverage | In-kind items and services | JOURNAVX Drug, PAIN | 2025 | |
| 2025-03-05 | Otsuka America Pharmaceutical, Inc. | $13 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-02-26 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-02-19 | Otsuka America Pharmaceutical, Inc. | $17 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-02-12 | Neurocrine BioSciences, Inc. | $13 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-30 | Lundbeck LLC | $15 | Food and Beverage | Cash or cash equivalent | ABILIFY MAINTENA Drug, PSYCHIATRY | 2025 | |
| 2025-01-23 | Otsuka America Pharmaceutical, Inc. | $12 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-01-15 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2025 | |
| 2025-01-14 | Otsuka America Pharmaceutical, Inc. | $23 | Food and Beverage | In-kind items and services | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2024-12-04 | Teva Pharmaceuticals USA, Inc. | $14 | Food and Beverage | In-kind items and services | UZEDY Drug, Neurology | 2024 | |
| 2024-11-13 | Lundbeck LLC | $15 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-31 | Alkermes, Inc. | $24 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-10-30 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-10-16 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2024 | |
| 2024-10-09 | Neurocrine BioSciences, Inc. | $17 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-10-02 | Lundbeck LLC | $20 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-09-18 | Janssen Pharmaceuticals, Inc | $13 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-09-05 | Noven Therapeutics, LLC | $18 | Food and Beverage | In-kind items and services | Secuado Drug, CNS Psychiatry | 2024 | |
| 2024-08-28 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $46 | Education | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-23 | Otsuka America Pharmaceutical, Inc. | $18 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-04-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $13 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-04-11 | Alkermes, Inc. | $20 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2024 | |
| 2024-03-28 | Alkermes, Inc. | $21 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-03-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $18 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Salem, IN, county Washington County, IN, state Indiana; placed by its city name.
| Measure | Place (city or town) Salem, IN | County Washington County, IN | State Indiana |
|---|---|---|---|
| Population B01003 | 6,489 | 28,212 | 6,851,073 |
| Population, 2020 census P1 | 6,371 | 28,182 | 6,785,528 |
| Median age B01002 | 43.1 | 41.5 | 38.1 |
| Under 18 B01001 | 18.4% | 22.8% | 23.3% |
| 65 and over B01001 | 21.4% | 18.6% | 16.8% |
| Households B11001 | 2,706 | 11,229 | 2,716,009 |
| Foreign born B05002 | 1.0% | 0.7% | 6.3% |
| Median household income B19013 | $56,538 | $64,641 | $71,957 |
| Median family income B19113 | $69,646 | $79,695 | $90,767 |
| Per capita income B19301 | $27,205 | $31,007 | $38,351 |
| Poverty rate B17001 | 25.7% | 14.4% | 12.3% |
| Unemployment rate B23025 | 4.8% | 3.2% | 4.3% |
| Civilian labor force B23025 | 3,176 | 13,852 | 3,472,016 |
| Mean commute (minutes) B08013 | 25.7 | 31.5 | 24.1 |
| Bachelor's degree or higher B15003 | 15.6% | 14.5% | 29.5% |
| Housing units B25001 | 2,838 | 12,222 | 2,976,568 |
| Owner-occupied B25003 | 73.7% | 82.1% | 70.6% |
| Renters B25003 | 26.3% | 17.9% | 29.4% |
| Median home value B25077 | $144,700 | $172,200 | $218,200 |
| Median gross rent B25064 | $690 | $780 | $1,062 |
| White, not Hispanic B03002 | 95.1% | 95.3% | 75.4% |
| Black B03002 | 0.1% | 0.3% | 9.1% |
| Hispanic or Latino B03002 | 2.7% | 1.5% | 8.6% |
| Asian B03002 | 0.0% | 0.1% | 2.6% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Economy now FRED unemployment 3.4% in Sep 2026 (3.7% a year earlier); per capita personal income $66,455 in 2025, up 28% in five years (+3.2% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Salem, IN.
Comments